⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6849393 | 0.74 | — | — | |
| SCHEMBL23291947 | 0.72 | — | — | |
| SCHEMBL5546239 | 0.69 | — | — | |
| SCHEMBL5717176 | 0.69 | — | — | |
| SCHEMBL28865793 | 0.68 | — | — | |
| SCHEMBL28010 | 0.67 | — | — | |
| SCHEMBL28964320 | 0.67 | — | — | |
| SCHEMBL717461 | 0.67 | — | — | |
| SCHEMBL715612 | 0.64 | — | — | |
| SCHEMBL30094252 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120137738-A | Compositions comprising iodofluorocarbons | 阿科玛法国公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119977753-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119954592-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119954594-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-09 | — | — | CN | claimed |
| CN-116669762-A | Incombustible liquid composition and use thereof | 东曹株式会社 | 2023-08-29 | — | — | CN | claimed |
| CN-114522254-B | Based on polyethylenimine nanoparticles 19 F MRI contrast agent and preparation thereof | 中山大学 | 2023-07-14 | — | — | CN | claimed |
| US-20230114828-A1 | COMPOSITION COMPRISING AN IODOFLUOROCARBON COMPOUND | ARKEMA FRANCE (FR) | 2023-04-13 | — | — | US | claimed |
| US-20230075839-A1 | METHOD FOR PRODUCING AN IODOFLUOROALKANE COMPOUND | ARKEMA FRANCE (FR) | 2023-03-09 | — | — | US | claimed |
| EP-4107140-A1 | METHOD FOR PRODUCING AN IODOFLUOROALKANE COMPOUND | ARKEMA FRANCE (FR) | 2022-12-28 | — | — | EP | claimed |
| CN-120137738-A | Compositions comprising iodofluorocarbons | 阿科玛法国公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119977753-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119954592-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119954594-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119954596-A | Process for producing iodofluorocarbon compounds | 阿科玛法国公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-2488493-A1 | SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES | F. Hoffmann-La Roche AG (CH) | 2012-08-22 | — | — | EP | disclosed |
| WO-2012035023-A1 | TRIAZINE-OXADIAZOLES | NOVARTIS AG (CH) | 2012-03-22 | — | — | WO | disclosed |
| WO-2011053509-A1 | ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2A RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2011-05-05 | — | — | WO | disclosed |
| WO-2011045292-A1 | SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-04-21 | — | — | WO | disclosed |
| EP-1963319-A1 | HETEROARYLPYRROLOPYRIDINONES ACTIVE AS KINASE INHIBITORS | Nerviano Medical Sciences S.r.l. (IT) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007071621-A1 | HETEROARYLPYRROLOPYRIDINONES ACTIVE AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2007-06-28 | — | — | WO | disclosed |